Trading / Browse Companies / Amylyx Stock

Amylyx Stock

amylyx.comHealthcareFounded: 2014Funding to Date: $203.25MM

Amylyx is a pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases.

Buy or sell Amylyx stockLearn more about a potential Amylyx IPO
Register for Details

For more details on financing and valuation for Amylyx, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Amylyx.

Register Today

Other companies like Amylyx in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.6B
Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Nutrafol
Sector
Healthcare
Last Round Est. Valuation
$150MM
Biosplice Therapeutics
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Cerebral
Sector
Healthcare
Last Round Est. Valuation
$4.8B
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Levels
Sector
Healthcare
Last Round Est. Valuation
$296.3MM

Trending Companies

Frequently Asked Questions